PHT Corporation (acquired by ERT, 27th February 2015) helps pharmaceutical companies and CROs conduct clinical studies with greater confidence, ease, and accuracy. PHT eCOA/ePRO systems enable clients to gain real-time insights through collecting and measuring how patients feel and function at the point of experience. This technology, and the service PHT provides, helps clients speed new therapies to market that ultimately improve patient quality of life around the world. From 600+ global trial experiences including 16+ regulatory approvals, PHT offers the regulatory, technology, and scientific expertise today’s market demands and patients deserve.
